Trilink Biotechnologies has announced that it is relaunching its oligonucleotide radiolabelling services.
Trilink discontinued the service in May 2009 after ordering trends in 2008 suggested that the market may no longer require it.
However, strong customer feedback led Trilink to bring back its radiolabelling services in September 2009.
Trilink provides modified nucleic acids and mid-scale oligonucleotide synthesis alongside technical support.
The company operates a GMP laboratory with a QSR environment.
It offers 35S and 3H labelling of both phosphodiester and phosphorothioate oligonucleotides, as well as additional modifications.
